1. Home
  2. IgG4-Related Disease Doctors Near Me
  3. Clinical Trials
  4. National Registry of IgG4-RD in China

IgG4-Related Disease Clinical Trials

Find IgG4-Related Disease Clinical Trials Near You

Find a DoctorCondition OverviewLatest AdvancesClinical TrialsTreatments

National Registry of IgG4-RD in China

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Methods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established. Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Conforming to the diagnostic criteria of IgG4-RD (2011);

Locations
Other Locations
China
Peking Union Medical College Hospital
RECRUITING
Beijing
Contact Information
Primary
Yunyun Fei
feiyunyun2013@hotmail.com
+8613681125226
Backup
Wen Zhang
zhangwen91@sina.com
Time Frame
Start Date: 2016-12
Estimated Completion Date: 2026-12
Participants
Target number of participants: 900
Related Therapeutic Areas
IgG4-Related Disease
Sponsors
Leads: Peking Union Medical College Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease

A Randomized, Phase 3, Double-blind, 52-week Study to Evaluate the Efficacy and Safety of Rilzabrutinib (SAR444671) Compared to Placebo in Adult Participants With Active IgG4-related Disease

Enrollment Status: Recruiting
Publish Date: April 08, 2026
Intervention Type: Drug
Study Phase: Phase 3

A Prospective, Randomized Controlled Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence Patients Receiving Glucocorticoid Maintenance Therapy/Glucocorticoid Combined With MMF Maintenance Therapy

A Prospective, Randomized Controlled Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence Patients Receiving Glucocorticoid Maintenance Therapy/Glucocorticoid Combined With MMF Maintenance Therapy

Enrollment Status: Recruiting
Publish Date: June 21, 2024
Intervention Type: Drug
Study Phase: Phase 4

A Prospective Study on the Effect of Minimal Residual Disease Detected by Fibroblast Activation Protein PET / CT on the Recurrence of IgG4-related Disease

A Prospective Study on the Effect of Minimal Residual Disease Detected by Fibroblast Activation Protein PET / CT on the Recurrence of IgG4-related Disease

Enrollment Status: Recruiting
Publish Date: August 05, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable
View All
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved